
ephalisumab

psoriasis chikilsikkunnathinaayi aadyam vipananam cheytha oottoo immyoon rogangal chikilsikkunnathinaayi roopakalppana cheythirunna oru munkaala labhyamaya marunnaan ephalisumab (vyaapaaranaamam raptiva, genentech, merck serono). -sumab" enna suffix soochippikkunnathu pole, aazhchayil orikkal subcutaneous kuthivayppiloode nalkunna oru recombinent humanised monoclonal antibodiyaanithu. lymphosite function-anubandha aantijan 1-nte sidi11eiii subunitumaayi ephalisumab bandhippikkukayum lymphosite aaktiveshan thadayunnathiloodeyum rakthakkuzhalukalil ninnu koshangalude tissukalilekkulla kaimaattam thadayunnathiloodeyum oru immunosaprasantaayi pravartthikkukayum cheiyunnu. marakamaaya mastishka anubaadhayumaayi bandhappettirunna ephalisumab 2009 ll vipaniyil ninnu pinvalichu.
bacteria sepsis, vairal meninchaitis, invasive fungus disease, lettant jessy vairas anubadha veendum sajeevamaakunnath moolamundaakunna mastishka anubadhayaaya progressive multifocal leukoensephalopathy (pml) enniva ariyappedunna paarshwafalangalil ulppedunnu. plake psoriasis rogikalil pii. emm. ellinte naalu kesukal report cheyyappettu, chikilsayilulla 500 rogikalil ekadesham oraal.
pll undakanulla saadhyatha kaaranam, europian medisins ejansiyum efda yathaakramam europian unionileyum americayileyum vipaniyil ninnu suspended cheyyaan shupaarsha cheythu. 2009 eprilil, genentech ink. yuu. esil ninnu raptiva swamedhayaa pinvalikkumennu prakhyaapichu.ezz. vipani.

